Clinical Trials Browser

Hematologic Neoplasms × talquetamab × 30 days × Clear all

NCT03399799 2026-06-05

MonumenTAL-1

Phase 1 Active not recruiting

279 enrolled 1 FDA

Other hematologic neoplasm

Hematologic Neoplasms

NCT04634552 2026-06-05

MonumenTAL-1

Phase 2 Recruiting

510 enrolled 1 FDA

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms